Inventor
PANG PETER K T
CA21 patents
⚠️ This page may combine multiple inventors who share the name “PANG PETER K T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PANG PETER K T
8 patentsUS5317010AMay 31, 1994
Parathyroid hormone analogues substituted at AA 25, 26, 27, and use in osteoporosis treatment
PANG PETER K T93 citations94
US5886012AMar 23, 1999
Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers
PANG PETER K T33 citations89
US5137878AAug 11, 1992
Composition and method for treatment of senile dementia
PANG PETER K T16 citations77
US4966893AOct 30, 1990
Method for treatment of senile dementia
PANG PETER K T15 citations77
US5457132AOct 10, 1995
Kit used in the treatment for hypertension using combination therapy involving exogenous calcium and calcium channel blockers
PANG PETER K T8 citations71
US5350771ASep 27, 1994
Method and treatment for hypertension using combination therapy involving exogenous calcium and calcium channel blockers
PANG PETER K T6 citations71
US5192664AMar 9, 1993
Parathyroid hypertensive factor, antibodies and uses thereof
PANG PETER K T3 citations56
US5354765AOct 11, 1994
Method of treatment for hypertension using combination therapy involving exogenous calcium and dihydropyridine calcium channel blockers
PANG PETER K T1 citations49
FX LIFE SCIENCES INTERNAT GMBH
4 patentsUS7413756B2Aug 19, 2008
Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
FX LIFE SCIENCES INTERNAT GMBH12 citations90
US7186423B2Mar 6, 2007
Processes of making North American ginseng fractions, products containing them, and uses as immunomodulators
FX LIFE SCIENCES INTERNAT GMBH12 citations90
US7195783B2Mar 27, 2007
Hypericin and hypericum extract: specific T-type calcium channel blocker, and their use as T-type calcium channel targeted therapeutics
FX LIFE SCIENCES INTERNAT GMBH12 citations79
US7358342B2Apr 15, 2008
Preparation derived from shark cartilage for treatment of diseased related to excessive PHF or excessive intracellular calcium
FX LIFE SCIENCES INTERNAT GMBH0 citations49
CV TECHNOLOGIES INC
3 patentsUS6156291ADec 5, 2000
Chemical and pharmacological standardization of herbal extracts
CV TECHNOLOGIES INC33 citations87
US5739274AApr 14, 1998
Active component of parathyroid hypertensive factor
CV TECHNOLOGIES INC6 citations56
US6060516AMay 9, 2000
N1 -propargylhydrazines, N2 -propargylhydrazines and their analogs for the treatment of depression, anxiety and neurodegeneration
CV TECHNOLOGIES INC0 citations43
C V TECHNOLOGIES INC
2 patentsUS6432454B1Aug 13, 2002
Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
C V TECHNOLOGIES INC27 citations90
US7067160B2Jun 27, 2006
Processes of making North American ginseng fractions, products containing them, and use as immunomodulators
C V TECHNOLOGIES INC8 citations71